Unveiling the game-changing diabetic drugs: Revolutionizing weight loss and diabetes management
The drug representative had a smug look; she knew she had a winner. She didn’t need to sell anything—the American public had already bought the story. There are very few drugs in history where patients are excited about the conversation and want to take a new medication. I am talking about the new class of diabetic drugs called GLP-1 (glucagon-like peptide) agonists. The particular drugs are Ozempic (semaglutide) and Mounjaro …